Yilmaz, D.T.; Gul, M.A.; Capraz, M.; Demir, H.D.; Tekcan, A.
Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers. Biomedicines 2025, 13, 2619.
https://doi.org/10.3390/biomedicines13112619
AMA Style
Yilmaz DT, Gul MA, Capraz M, Demir HD, Tekcan A.
Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers. Biomedicines. 2025; 13(11):2619.
https://doi.org/10.3390/biomedicines13112619
Chicago/Turabian Style
Yilmaz, Duygu Tozcu, Mehmet Ali Gul, Mustafa Capraz, Hatice Dortok Demir, and Akin Tekcan.
2025. "Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers" Biomedicines 13, no. 11: 2619.
https://doi.org/10.3390/biomedicines13112619
APA Style
Yilmaz, D. T., Gul, M. A., Capraz, M., Demir, H. D., & Tekcan, A.
(2025). Investigation of Serum Visfatin and Chemerin Levels in Type 2 Diabetes and Obesity Patients: Their Potential Role as Clinical and Biomarkers. Biomedicines, 13(11), 2619.
https://doi.org/10.3390/biomedicines13112619